Loading clinical trials...
Loading clinical trials...
A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief with a Lidocaine Test Dose
Conditions
Interventions
Bupivacaine Hydrochloride
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
December 1, 2023
Primary Completion Date
January 31, 2026
Completion Date
January 31, 2026
Last Updated
February 10, 2025
NCT06572241
NCT07411352
NCT07278895
NCT07045675
NCT06849726
NCT07392112
Lead Sponsor
Brigham and Women's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions